Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Estee Lauder Companies Inc (EL) vs Novavax Inc (NVAX) Price & Performance

Estee Lauder Companies IncTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

Estee Lauder Companies Inc vs Novavax Inc — how do they compare? Estee Lauder Companies Inc trades at $88.05 (market cap $31.76B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Estee Lauder Companies Inc is far larger — about 24.2× Novavax Inc's market cap, and Estee Lauder Companies Inc pays a 1.59% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.

ELNVAX
Market Cap
$31.76B$1.31B
Sector
Consumer StaplesHealth
52-Week High
$119.61$11.19
52-Week Low
$67.23$6.22
Enterprise Value
$37.93B$889.30M
Dividend Yield
1.59%

Returns comparison

Trailing returns across standard periods

About Estee Lauder Companies Inc

Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

Read more on EL

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX